Book Online
or Call 1-855-SAUSALITO
Sign In
|
Register
|
About Sausalito
|
Contact Us
Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast
|
Traffic
Online Reservations
Cavallo Point
Casa Madrona
The Gables Inn
Mill Valley Inn
Acqua Hotel
Larkspur Hotel
Waters Edge
The Lodge at Tiburon
Sausalito Hotels
Vacation Packages
San Francisco Hotels
Event Calendar
Art Galleries
Arts and Culture
Amusement Parks
Nightlife
Attractions
Sausalito Ferry
Public Parks
Entertainment
Movie Show Times
TV Listings
Celebrities on TV
Museums and Historical Places
Environmental
Food and Wine
Day Trips
Visit San Francisco
Spas and Massage
Apartments
Arts, Culture, & Entertainment
Amusement and Water Parks
Art Galleries & Dealers
Art Instruction & Schools
Attractions
Environmental
Food and Wine Entertainment
Marin Arts and Culture
Movie Theaters & Movie Rentals
Museums
Music Venues
Photographers
Photography - Commercial
Automotive
Auto Glass & Detailing
Auto Repair Service
Gas Stations
New & Used Car Dealers
Boating
Boat Rides
Boat Storage
Boats & Chartered Boats
Harbors, Marinas & Yacht Clubs
Private Yacht Clubs
Business & Professional Services
Employment Agencies
Industrial Supplies & Services
Insurance Agents & Agencies
Mailing & Shipping
Photography - Commercial
Private Investigators
Rubbish & Garbage Removal
Security Systems
Self Storage
Community & City Services
Chamber of Commerce
City & County Government
City Hall
City Maps & Guides
City of Sausalito
Community Centers
Fire Department
Library
Police Department
Post Offices
State Government
Construction and Contractors
Architects
General Contractors
Home Remodeling
Landscaping
Plumbers
Education and Schools
Nursery Schools & Kindergarten
Private Schools
Public Schools
Tutoring
Financial and Legal Services
Accountants & Tax
Banks
Bookkeeping
Financial Consultants
Lawyers & Attorneys at Law
Public Notaries
Health & Child Care
Acupuncture / Alternative Medicine
Child Protective Services
Chiropractors
Day Care
Dentists
Doctors, Physicians & Surgeons
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Hypnotherapy
Medical Equipment
Physical Therapists
Psychiatrists & Therapists
Specialists
Home and Garden
Cleaning Services
Doors & Windows
Floor Coverings
Interior Design
Landscaping
Moving Companies
Pools, Spas & Saunas
Remodeling
Media
Local TV Stations
Magazine Publishers
Newspapers
Online Publications
Print Publications
Radio Stations
Nightclubs & Music
Organizations, Foundations, & Associations
Business/Professional
Charitable Foundations
Common Interest Groups
Non-Profits
Youth Organizations
Pets
Dog & Cat Grooming
Kennels & Pet Boarding
Pet Hospitals
Pet Supplies
Veterinarians
Real Estate
Apartments
Appraisers
Commercial Development
Commercial Management
Commercial Real Estate
Construction
Developers
Mortgage Brokers
Property Management
Residential Real Estate
Religion
Restaurants, Food & Bars
American
Bakery
Breakfast
Burgers
Chinese
Coffee & Caf�s
Deli
Fast Food
Free Wi-Fi
French
Himalayan
Ice Cream / Frozen Yogurt
Indian
Italian
Mexican
Ocean View Restaurants
Pizza
Seafood
Sports Bars
Steakhouse
Sushi
Thai Food
Wine Tasting Room
Salons, Spas, & Fitness
Barbers
Beauty Salons
Cosmetics
Fitness Equipment
Gyms & Health Clubs
Manicures & Pedicures
Massages
Personal Trainers
Spas
Waxing
Sausalito Hotels & Inns
Bed & Breakfasts
Hotels, Motels & Resorts
Vacation Rentals
Shopping
Book Stores
Children's Clothing
Electronics
Florists
Furniture & Appliances
Gifts & Specialty Shops
Grocery Stores
Handbags
Jewelers
Marin County Shopping Centers
Men & Women's Clothing
Men's Clothing
Shoes
Sportswear
Women's Clothing
Yoga
Sports and Recreation
Bicycle Rentals & Retailers
Boats & Chartered Boats
Kayaking
Public Parks
Walking Trails
Technology & Utility Services
Computer Parts & Supplies
Computer Repair
Electric Companies
Internet Service Providers
Telephone & Cable Companies
Website Development & Design
Travel and Transportation
Airport Transportation
Bike Rentals
Buses Charter & Rental
Ferry
Limo Car Services
Taxi Cabs
Travel Agencies
Weddings
Caterers
Planners
Venues
Wi-Fi Hotspots
Your Business Here
Ferry Schedule
Surf Report
Coupons
Contests
Classifieds
Site Forums
Photo Gallery
Story Archives
Advertise With Us
Free Email
Send Flowers
Search Hotels in Sausalito
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Sanofi - Aventis Groupe
< Previous
1
2
3
4
5
Next >
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations
May 02, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Annual General Meeting of April 30, 2024
April 30, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
April 25, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
April 23, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
April 17, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Availability of the Q1 2024 Memorandum for modelling purposes
March 22, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis
March 11, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria
February 24, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
February 23, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Dupixent® sBLA accepted for FDA Priority Review for treatment of COPD with type 2 inflammation
February 23, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
February 22, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)
February 16, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Phase 2 data published in NEJM show potential of frexalimab as high-efficacy therapy in relapsing MS
February 15, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Peer support, flexible work arrangements, salary for a year: Sanofi launches global program for employees affected by cancer and critical illnesses
February 05, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline
February 01, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: François-Xavier Roger appointed Chief Financial Officer, member of Sanofi Executive Committee
February 01, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE)
January 25, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline
January 23, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Brian Foard appointed Head of Specialty Care Global Business Unit, member of Sanofi Executive Committee
January 09, 2024
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Sanofi announces end of program evaluating tusamitamab ravtansine after a 2L NSCLC Phase 3 trial did not meet a primary endpoint
December 21, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Availability of the Q4 2023 Memorandum for modelling purposes
December 15, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
December 15, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Statement on FTC challenge to proposed license agreement with Maze Therapeutics
December 11, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone
December 10, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplant
December 07, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in Immunology
December 06, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
November 27, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Specialty Care growth, strong launch uptake of Beyfortus® and ALTUVIIIO® drive solid Q3 results
October 27, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Sanofi Enters Next Chapter of Play to Win Strategy
October 27, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
Press Release: Dupixent® (dupilumab) Phase 3 Results show sustained efficacy for up to one year in children 1 to 11 years of age with eosinophilic esophagitis (EoE)
October 22, 2023
From
Sanofi - Aventis Groupe
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Sausalito Home
|
Lodging
|
Sausalito Restaurants
|
Things To Do
|
Sausalito Events Calendar
|
Shopping
|
Sausalito Real Estate
|
Sausalito Directory Listings
|
Sausalito Blog
|
Jobs
|
More
Photos copyright by
Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.
